Couverture de Medscape InDiscussion: Obesity

Medscape InDiscussion: Obesity

Medscape InDiscussion: Obesity

De : Medscape
Écouter gratuitement

À propos de cette écoute

Join Dr Robert Kushner for Medscape InDiscussion: Obesity, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982630). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.Copyright 2023, Medscape Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Obesity Rx: How to Use New Medications in Clinic
      Aug 3 2023

      Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more.

      Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982636). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

      Resources

      Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment

      Drugs for Treating Obesity https://pubmed.ncbi.nlm.nih.gov/34783910/

      Control-Theory Models of Body-weight Regulation and Body-weight-regulatory Appetite https://pubmed.ncbi.nlm.nih.gov/31494154/

      Obesogenic Environments: Current Evidence of the Built and Food Environments https://pubmed.ncbi.nlm.nih.gov/28449616/

      FDA-approved Pharmacotherapy for Weight Loss Over the Last Decade https://pubmed.ncbi.nlm.nih.gov/36277516/

      Tirzepatide https://pubmed.ncbi.nlm.nih.gov/36251836/

      New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics https://pubmed.ncbi.nlm.nih.gov/36706749/

      Once-Weekly Semaglutide in Adults With Overweight or Obesity https://pubmed.ncbi.nlm.nih.gov/34192447/

      Tirzepatide Once Weekly for the Treatment of Obesity https://pubmed.ncbi.nlm.nih.gov/35658024/

      Bariatric Surgery https://emedicine.medscape.com/article/197081-overview

      FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

      Body Mass Index https://medlineplus.gov/ency/article/007196.htm

      Descriptive Analysis of Reported Adverse Events Associated With Anti-obesity Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013-2020 https://pubmed.ncbi.nlm.nih.gov/34564826/

      Antiobesity Drug Therapy: An Individualized and Comprehensive Approach https://pubmed.ncbi.nlm.nih.gov/34341028/

      Barriers and Solutions for Prescribing Obesity Pharmacotherapy https://pubmed.ncbi.nlm.nih.gov/32418592/

      Addressing Insurance-related Barriers to Novel Antiobesity Medications: Lessons to Be Learned From Bariatric Surgery https://pubmed.ncbi.nlm.nih.gov/36190393/

      Certifying Physicians in the Treatment of Obesity https://www.abom.org/

      Afficher plus Afficher moins
      22 min
    • 'Diabesity' in Clinic: Prevention and Management
      Jul 6 2023

      Diabetes and obesity are on the rise, and there are new tools to help the prevention and management of this twin epidemic of "diabesity" in primary care. Drs Robert Kushner and Tim Garvey discuss.

      Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982635). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

      Resources

      Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment

      Type 2 Diabetes Mellitus https://emedicine.medscape.com/article/117853-overview

      Diabesity https://diabetesjournals.org/clinical/article/40/4/392/147743/Diabesity

      National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States https://www.cdc.gov/diabetes/data/statistics-report/index.html

      Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016 https://pubmed.ncbi.nlm.nih.gov/31860047/

      Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017 https://pubmed.ncbi.nlm.nih.gov/34427600/

      CDC Diabetes and Obesity Maps https://www.cdc.gov/diabetes/data/center/slides.html

      Diabetes Technology: Standards of Care in Diabetes – 2023 https://pubmed.ncbi.nlm.nih.gov/36507635/

      American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan – 2022 Update https://pubmed.ncbi.nlm.nih.gov/35963508/

      Mediterranean Diet and Obesity-Related Disorders: What Is the Evidence? https://pubmed.ncbi.nlm.nih.gov/36178601/

      The Look AHEAD Study: A Description of the Lifestyle Intervention and the Evidence Supporting It https://pubmed.ncbi.nlm.nih.gov/16855180/

      Durability of a Primary Care–Led Weight-Management Intervention for Remission of Type 2 Diabetes: 2-Year Results of the DiRECT Open-Label, Cluster-Randomised Trial https://pubmed.ncbi.nlm.nih.gov/30852132/

      Semaglutide https://reference.medscape.com/drug/ozempic-rybelsus-wegovy-semaglutide-1000174

      Liraglutide https://reference.medscape.com/drug/victoza-saxenda-liraglutide-999449

      Tirzepatide Once Weekly for the Treatment of Obesity https://pubmed.ncbi.nlm.nih.gov/35658024/

      Glucagon-Like Peptide 1 Receptor Agonists https://www.ncbi.nlm.nih.gov/books/NBK551568/

      Dulaglutide Injection https://medlineplus.gov/druginfo/meds/a614047.html

      Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK576405/

      Incretin Hormones: Their Role in Health and Disease https://pubmed.ncbi.nlm.nih.gov/29364588/

      Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Antagonists as Anti-Diabetic Agents https://pubmed.ncbi.nlm.nih.gov/29412817/

      Afficher plus Afficher moins
      19 min
    • Medical Evaluation of the Patient Who Presents With Obesity
      Jun 6 2023

      How do you medically evaluate a person who presents with obesity? Drs Robert Kushner and Amanda Velazquez share practical tools and pearls for community clinicians.

      Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982633). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

      Resources

      Obesity Treatment & Management https://emedicine.medscape.com/article/123702-treatment

      A Primer on Smoking Cessation in Primary Care https://www.medscape.com/viewarticle/864524_3

      Reasons for Underutilization of Bariatric Surgery: The Role of Insurance Benefit Design https://pubmed.ncbi.nlm.nih.gov/30425002/

      Antiobesity Drug Therapy: An Individualized and Comprehensive Approach https://pubmed.ncbi.nlm.nih.gov/34341028/

      Taking a Weight History – Using Mnemonics to Learn a Missing Skill in Medical Education [Version 1] https://mededpublish.org/articles/6-215

      The Broadening Domain of the Metabolic Syndrome https://www.medscape.org/viewarticle/508282

      Mallampati Classification https://emedicine.medscape.com/article/2172419-overview

      Acanthosis Nigricans https://emedicine.medscape.com/article/1102488-overview

      Cushing's Syndrome https://www.niddk.nih.gov/health-information/endocrine-diseases/cushings-syndrome

      Clinical Use of the Edmonton Obesity Staging System for the Assessment of Weight Management Outcomes in People With Class 3 Obesity https://pubmed.ncbi.nlm.nih.gov/35267942/

      The Progression of Cardiometabolic Disease: Validation of a New Cardiometabolic Disease Staging System Applicable to Obesity https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866217/

      Modern Epigenetics Methods in Biological Research https://pubmed.ncbi.nlm.nih.gov/32645449/

      Afficher plus Afficher moins
      21 min

    Ce que les auditeurs disent de Medscape InDiscussion: Obesity

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.